NASDAQ:PAHC - Phibro Animal Health Stock Price, News & Analysis

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Phibro Animal Health declared a quarterly dividend on Monday, July 29th. Shareholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share on Wednesday, September 25th. This represents a $0.48 annualized dividend and a yield of 1.54%. The ex-dividend date is Tuesday, September 3rd. View Phibro Animal Health's Dividend History.

Phibro Animal Health Corp (NASDAQ:PAHC) issued its quarterly earnings data on Monday, May, 6th. The company reported $0.39 EPS for the quarter, missing the Zacks' consensus estimate of $0.43 by $0.04. The business had revenue of $205.70 million for the quarter, compared to analyst estimates of $214.94 million. Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The company's revenue was down 1.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.46 EPS. View Phibro Animal Health's Earnings History.

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Tuesday, August 27th 2019. View Earnings Estimates for Phibro Animal Health.

Phibro Animal Health will be holding an earnings conference call on Wednesday, August 28th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8778535634.

4 equities research analysts have issued 12-month price objectives for Phibro Animal Health's shares. Their forecasts range from $25.00 to $46.00. On average, they expect Phibro Animal Health's stock price to reach $37.6667 in the next twelve months. This suggests a possible upside of 20.7% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

News articles about PAHC stock have been trending negative on Sunday, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Phibro Animal Health earned a news sentiment score of -2.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Phibro Animal Health.

Phibro Animal Health saw a increase in short interest in July. As of July 31st, there was short interest totalling 796,900 shares, an increase of 30.3% from the June 30th total of 611,800 shares. Based on an average trading volume of 165,700 shares, the days-to-cover ratio is currently 4.8 days. Approximately 3.9% of the company's shares are short sold. View Phibro Animal Health's Current Options Chain.

Some companies that are related to Phibro Animal Health include Ascendis Pharma A/S (ASND), GW Pharmaceuticals PLC- (GWPH), ACADIA Pharmaceuticals (ACAD), Blueprint Medicines (BPMC), FibroGen (FGEN), Allakos (ALLK), Mirati Therapeutics (MRTX), United Therapeutics (UTHR), Ultragenyx Pharmaceutical (RARE), Nektar Therapeutics (NKTR), Alkermes (ALKS), BridgeBio Pharma (BBIO), Taro Pharmaceutical Industries (TARO), Evotec (EVTCY) and Global Blood Therapeutics (GBT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Ophthotech (OPHT) and RetailMeNot (SALE).

Phibro Animal Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.04%), Vanguard Group Inc. (5.58%), Fiduciary Management Inc. WI (2.65%), Janus Henderson Group PLC (2.37%), Janus Henderson Group PLC (2.37%) and Renaissance Technologies LLC (1.87%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Richard G Johnson. View Institutional Ownership Trends for Phibro Animal Health.

PAHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, D. E. Shaw & Co. Inc., Prudential Financial Inc., Wells Fargo & Company MN, Citadel Advisors LLC, AQR Capital Management LLC and Invesco Ltd.. Company insiders that have sold Phibro Animal Health company stock in the last year include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras and Jack Bendheim. View Insider Buying and Selling for Phibro Animal Health.

PAHC stock was purchased by a variety of institutional investors in the last quarter, including Fiduciary Management Inc. WI, Janus Henderson Group PLC, Janus Henderson Group PLC, Nuveen Asset Management LLC, Marshall Wace LLP, Vanguard Group Inc., Tocqueville Asset Management L.P. and Bank of America Corp DE. View Insider Buying and Selling for Phibro Animal Health.

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PAHC stock can currently be purchased for approximately $31.21.

Phibro Animal Health has a market capitalization of $1.26 billion and generates $820 million in revenue each year. The company earns $64.88 million in net income (profit) each year or $1.74 on an earnings per share basis. Phibro Animal Health employs 1,500 workers across the globe.View Additional Information About Phibro Animal Health.

The official website for Phibro Animal Health is http://www.pahc.com/.

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]